317 related articles for article (PubMed ID: 1901597)
21. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy.
Moghrabi A; Friedman HS; Burger PC; Tien R; Oakes WJ
J Neurosurg; 1993 Aug; 79(2):223-7. PubMed ID: 8331404
[TBL] [Abstract][Full Text] [Related]
23. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
Prados MD; Edwards MS; Rabbitt J; Lamborn K; Davis RL; Levin VA
J Neurooncol; 1997 May; 32(3):235-41. PubMed ID: 9049885
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of chiasmal gliomas in children].
Helcl F
Bratisl Lek Listy; 1995 Apr; 96(4):223-6. PubMed ID: 7552387
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.
Kato T; Sawamura Y; Tada M; Ikeda J; Ishii N; Abe H
J Neurooncol; 1998 May; 37(3):263-70. PubMed ID: 9524084
[TBL] [Abstract][Full Text] [Related]
27. Results of the treatment of children with recurrent gliomas with lomustine and vincristine.
Lefkowitz IB; Packer RJ; Sutton LN; Siegel KR; Bruce DA; Evans AE; Schut L
Cancer; 1988 Mar; 61(5):896-902. PubMed ID: 3338054
[TBL] [Abstract][Full Text] [Related]
28. Chiasmatic optic glioma treated with chemotherapy. A preliminary report.
Rosenstock JG; Packer RJ; Bilaniuk L; Bruce DA; Radcliffe JL; Savino P
J Neurosurg; 1985 Dec; 63(6):862-6. PubMed ID: 4056900
[TBL] [Abstract][Full Text] [Related]
29. Optico-hypothalamic glioma: an analysis of 16 cases.
Nishio S; Takeshita I; Fujiwara S; Fukui M
Childs Nerv Syst; 1993 Sep; 9(6):334-8. PubMed ID: 8269416
[TBL] [Abstract][Full Text] [Related]
30. Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
Peyrl A; Azizi A; Czech T; Gruber-Olipitz M; Jones N; Haberler C; Prayer D; Autzinger E; Slavc I
Pediatr Blood Cancer; 2009 Apr; 52(4):476-80. PubMed ID: 19061223
[TBL] [Abstract][Full Text] [Related]
31. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
[TBL] [Abstract][Full Text] [Related]
32. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.
Janss AJ; Grundy R; Cnaan A; Savino PJ; Packer RJ; Zackai EH; Goldwein JW; Sutton LN; Radcliffe J; Molloy PT
Cancer; 1995 Feb; 75(4):1051-9. PubMed ID: 7842408
[TBL] [Abstract][Full Text] [Related]
33. Combined intraarterial carboplatin, intraarterial etoposide phosphate, and IV Cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children.
Osztie E; Várallyay P; Doolittle ND; Lacy C; Jones G; Nickolson HS; Neuwelt EA
AJNR Am J Neuroradiol; 2001 May; 22(5):818-23. PubMed ID: 11337321
[TBL] [Abstract][Full Text] [Related]
34. [A clinicopathological study of 16 cases with optico-hypothalamic glioma].
Nitta T; Sato K
No Shinkei Geka; 1995 Mar; 23(3):217-22. PubMed ID: 7700489
[TBL] [Abstract][Full Text] [Related]
35. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.
Prados M; Rodriguez L; Chamberlain M; Silver P; Levin V
Neurosurgery; 1989 Jun; 24(6):806-9. PubMed ID: 2546093
[TBL] [Abstract][Full Text] [Related]
36. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
[TBL] [Abstract][Full Text] [Related]
37. Intracranial visual pathway gliomas in children with neurofibromatosis.
Packer RJ; Bilaniuk LT; Cohen BH; Braffman BH; Obringer AC; Zimmerman RA; Siegel KR; Sutton LN; Savino PJ; Zackai EH
Neurofibromatosis; 1988; 1(4):212-22. PubMed ID: 3152473
[TBL] [Abstract][Full Text] [Related]
38. Chiasmal gliomas: appearance and long-term changes demonstrated by computerized tomography.
Fletcher WA; Imes RK; Hoyt WF
J Neurosurg; 1986 Aug; 65(2):154-9. PubMed ID: 3088222
[TBL] [Abstract][Full Text] [Related]
39. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors.
Levin VA; Edwards MS; Wright DC; Seager ML; Schimberg TP; Townsend JJ; Wilson CB
Cancer Treat Rep; 1980; 64(2-3):237-44. PubMed ID: 7407756
[TBL] [Abstract][Full Text] [Related]
40. Salvage chemotherapy for recurrent primary brain tumors in children.
van Eys J; Baram TZ; Cangir A; Bruner JM; Martinez-Prieto J
J Pediatr; 1988 Sep; 113(3):601-6. PubMed ID: 3411410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
